Key result
SGLT2i warrant consideration for a potential antiarrhythmic role after AF ablation.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Insufficient to guide SGLT2 inhibitor use after AF ablation; leaves open antiarrhythmic effects for randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2025) studied this question. Sodium-glucose cotransporter-2 inhibitors warrant reconsideration regarding their potential antiarrhythmic role after atrial fibrillation ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: